Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Medpace Holdings, Inc. Director's Dealing 2025

Jul 30, 2025

30442_dirs_2025-07-29_ba1128c1-5005-4731-b95b-e85d56447124.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Medpace Holdings, Inc. (MEDP)
CIK: 0001668397
Period of Report: 2025-07-28

Reporting Person: EWALD STEPHEN P (General Counsel & Corp. Secy.)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-07-28 Common Stock S 3000 $450 Disposed 10343 Direct

Footnotes

F1: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.